Vontobel Holding Ltd. Sells 185,552 Shares of CME Group Inc. $CME

Posted by Casey Walker on Jun 13th, 2026

Vontobel Holding Ltd. decreased its position in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 9.6% in the 4th quarter, Holdings Channel reports. The firm owned 1,743,756 shares of the financial services provider’s stock after selling 185,552 shares during the quarter. CME Group accounts for about 1.5% of Vontobel Holding Ltd.’s portfolio, making the stock its 13th largest holding. Vontobel Holding Ltd.’s holdings in CME Group were worth $476,185,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Norges Bank bought a new stake in shares of CME Group in the 4th quarter valued at $1,523,241,000. Sanders Capital LLC bought a new stake in shares of CME Group in the 3rd quarter valued at $1,006,932,000. Strive Asset Management LLC bought a new stake in shares of CME Group in the 3rd quarter valued at $636,487,000. Life Cycle Investment Partners Ltd bought a new stake in shares of CME Group in the 4th quarter valued at $217,656,000. Finally, Viking Global Investors LP bought a new stake in shares of CME Group in the 2nd quarter valued at $164,648,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Stock Performance

NASDAQ CME opened at $269.53 on Friday. The company has a fifty day simple moving average of $284.79 and a 200 day simple moving average of $288.07. CME Group Inc. has a 12-month low of $244.56 and a 12-month high of $329.16. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The company has a market cap of $97.67 billion, a P/E ratio of 23.00, a PEG ratio of 2.93 and a beta of 0.21.

CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.11 by $0.25. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The business had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.77 billion. During the same quarter last year, the firm posted $2.80 EPS. CME Group’s revenue was up 14.5% compared to the same quarter last year. Sell-side analysts predict that CME Group Inc. will post 12.28 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be given a $1.30 dividend. The ex-dividend date of this dividend is Tuesday, June 9th. This represents a $5.20 annualized dividend and a yield of 1.9%. CME Group’s dividend payout ratio (DPR) is presently 44.37%.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the stock. JPMorgan Chase & Co. lifted their price objective on shares of CME Group from $266.00 to $271.00 and gave the company an “underweight” rating in a research note on Thursday, April 16th. Rothschild & Co Redburn upgraded shares of CME Group from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $316.00 to $323.00 in a research note on Thursday. Piper Sandler lifted their price objective on shares of CME Group from $313.00 to $329.00 and gave the company an “overweight” rating in a research note on Wednesday, April 15th. The Goldman Sachs Group lowered their price objective on shares of CME Group from $275.00 to $267.00 and set a “sell” rating for the company in a research note on Thursday, April 23rd. Finally, Jefferies Financial Group lowered their price objective on shares of CME Group from $356.00 to $349.00 and set a “buy” rating for the company in a research note on Thursday, April 9th. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $305.71.

Read Our Latest Stock Analysis on CME Group

Key Headlines Impacting CME Group

Here are the key news stories impacting CME Group this week:

Positive Sentiment: CME announced four new E-mini futures contracts tied to broad-market equity benchmarks, plus new Micro E-mini options on the S&P 500 and Nasdaq-100. These launches could attract more trading volume by giving investors additional, lower-cost ways to hedge and gain market exposure. CME Group to Expand Equity Index Suite with Launch of Four New E-mini Futures Contracts
Positive Sentiment: The company also said it will expand 24/7 trading for WTI crude oil and gold, which could improve price discovery and make CME’s metals and energy products more attractive to global traders operating outside normal market hours. CME Group to Expand 24/7 Trading for WTI Crude Oil and Gold
Positive Sentiment: CME launched Nasdaq CME Crypto Index futures and is moving deeper into digital-asset derivatives, giving investors regulated exposure to major cryptocurrencies and potentially opening another growth avenue for the exchange. CME Group Launches Crypto Index Futures Tracking Bitcoin, Solana and XRP
Neutral Sentiment: Erste Group Bank slightly raised its FY2026 EPS estimate for CME, signaling stable earnings expectations rather than a major change in outlook. MarketBeat report on CME estimate update
Negative Sentiment: Some commentary around the CFTC’s crypto oversight has raised concerns about regulatory pressure and market criticism, which could create uncertainty for CME’s expanding crypto-related products. CFTC’s Lone Chair Selig Expands Grip Over Crypto and Prediction Markets

Insider Activity at CME Group

In related news, insider Hilda Harris Piell sold 5,753 shares of CME Group stock in a transaction on Monday, May 18th. The shares were sold at an average price of $304.63, for a total value of $1,752,536.39. Following the completion of the sale, the insider owned 27,702 shares of the company’s stock, valued at approximately $8,438,860.26. This trade represents a 17.20% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, General Counsel Jonathan L. Marcus sold 3,291 shares of CME Group stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $333.37, for a total transaction of $1,097,120.67. Following the transaction, the general counsel directly owned 7,192 shares in the company, valued at $2,397,597.04. This represents a 31.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 44,044 shares of company stock valued at $13,297,507. 0.30% of the stock is owned by company insiders.

CME Group Company Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.